Medical and Pharmaceutical Breath Diagnostics now offering a compelling investment opportunity The lung cancer breath test developer is enabling investors to buy US$3 shares through a Reg CF financing Rowan DunneMay 7, 2025
Medical and Pharmaceutical Chinese researchers develop breath analysis tech for lung cancer detection It works by identifying abnormal levels of isoprene -- a volatile organic compound Rowan DunneNovember 6, 2024